Two Sigma Investments
AVBP icon

Two Sigma Investments’s ArriVent BioPharma AVBP Stock Holding History

Two Sigma Investments’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Sell
48,682
-28,797
-37% -$650K ﹤0.01% 3175
2025
Q4 		$1.56M Sell
77,479
-14,239
-16% -$296K ﹤0.01% 2624
2025
Q3 		$1.69M Buy
+91,718
New +$1.8M ﹤0.01% 2238
2025
Q2 		– Sell
-41,381
Closed -$765K – 3608
2025
Q1 		$765K Buy
+41,381
New +$1.01M ﹤0.01% 2323

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments's AVBP Position: Q1 2026 in Review

Two Sigma Investments reduced its ArriVent BioPharma (AVBP) stake by 37% in Q1 2026, selling an estimated $650K and leaving 48,682 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3175.

Two Sigma Investments first reported a position in AVBP in Q1 2025 and has held it in 4 quarters since. The position peaked at $1.69M in Q3 2025. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Two Sigma Investments held 48,682 shares of ArriVent BioPharma worth $1.12M as of Q1 2026.
  • Two Sigma Investments sold 28,797 ArriVent BioPharma shares in Q1 2026, an estimated $650K.
  • ArriVent BioPharma made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3175 holding.
  • Two Sigma Investments first reported a position in ArriVent BioPharma in Q1 2025 and has held it in 4 quarters since.
  • Two Sigma Investments's ArriVent BioPharma position peaked at $1.69M in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.